Article info

Download PDFPDF
Simvastatin Induces Death of Multiple Myeloma Cell Lines
  1. From the Department of Medicine (N.G., M.L.), Oncogenetic (N.G., L.D., S.Y., M.L.) and Hematology (H.S., J.R.) Laboratories, Sapir Medical Center, Meir Hospital, Kfar-Saba, Israel; and Sackler Faculty of Medicine (M.L.), Tel Aviv University, Tel Aviv, Israel.
  2. Supported by Tel Aviv University research grant #06-0138-0296-390007. Merck generously provided the simvastatin used in this study.
  3. Address correspondence to: Dr. Liat Drucker, Oncogenetic Laboratory, Sapir Medical Center, Meir Hospital, Kfar Sava 44281, Israel; e-mail: druckerl{at}clalit.org.il.

Citation

Gronich N, Drucker L, Shapiro H, et al
Simvastatin Induces Death of Multiple Myeloma Cell Lines

Publication history

  • First published January 4, 2016.
Online issue publication 
January 04, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.